MEMStim

Executive Summary

MEMStim is a private medical device outsource manufacturer (MDO) and OEM based in Minneapolis, specializing in the neurostimulation market. Founded in 2016, the company leverages advanced microfabrication and 3D printing technologies to produce high-density, biocompatible electrode leads for implantable neurostimulation devices. By focusing on automated, high-quality manufacturing, MEMStim aims to make neuromodulation devices more affordable, smaller, and more efficient, ultimately improving patient outcomes. The neurostimulation market is rapidly expanding, driven by growth in chronic pain management, Parkinson's disease, and other neurological disorders. MEMStim's differentiated manufacturing capabilities position it as a key supplier to both established and emerging neurostimulation companies. Although the company remains privately held and has limited publicly available financials, its strategic focus on a high-growth niche and its technological edge suggest strong upside potential. Key risks include reliance on a limited number of OEM customers and the need to continually innovate to maintain competitiveness. Overall, MEMStim represents a compelling opportunity in the medical device contract manufacturing space, with catalysts such as new customer contracts, capacity expansion, and potential funding rounds.

Upcoming Catalysts (preview)

• Q4 2026Major OEM Contract for High-Density Electrode Leads60% success
• Q3 2026Series B Funding to Scale Manufacturing Capacity70% success
• Q2 2027FDA 510(k) Clearance for Proprietary Lead Design40% success